- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00800644
Pelvic Fractures and Radiation Therapy for Cervical Cancer
Evaluation of Bone Density and Pelvic Fractures in Women Undergoing Definitive Pelvic Radiation Therapy for Cervical, Endometrial or Vaginal Cancer
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
If you agree to take part in this study, the following tests and procedures will be performed before radiation therapy:
- You will have a bone mineral density test. A bone mineral density test measures bone loss over time, identifies osteoporosis (a disease of the bones that causes them to be weak and easily breakable) or the risk for developing osteoporosis, and checks your risk for fractures. During the test, you will lie on a cushioned table while a mechanical arm-like device will pass over your body. This device will not touch you.
- During your routine visits, you may have either a magnetic resonance imaging (MRI) scan or a computed tomography (CT) scan of the pelvis as part of your standard of care. A PET scan may be done if your doctor thinks it is necessary. These scans will be reviewed by the research staff of this study to determine your response to therapy, determine if your cancer has returned, and to look for broken bones.
- Blood (about 1 tablespoon) will be drawn to test for bone turnover.
- Blood (about 2 to 3 teaspoons) will be drawn for tests to measure the level of vitamin D, calcium, phosphorus, and parathyroid hormone (PTH).
- Researchers will collect information from your medical record. This information will include your medical history, your ethnicity, if you have had any bone fractures, if you have a history of bone fractures in your family, and your use of tobacco and/or alcohol.
At 4 weeks after start of radiation therapy, blood (about 2 to 3 teaspoons) will be drawn to test for bone turnover.
At 3 months, 1 year, and 2 years after you complete radiation:
- You will have a bone mineral density test.
- You may have either an MRI or CT scan of the pelvis as part of your standard of care. A PET scan may be done if your doctor thinks it is necessary. These scans will be reviewed by the research staff of this study to determine your response to therapy, determine if your cancer has returned, and to look for broken bones.
- Blood (about 2 tablespoons) will be drawn for tests to measure the level of vitamin D and to test for bone turnover.
Length of Study:
You will be off study 2 years after you complete radiation.
After 2 years and for up to 5 years, results of bone density tests or scans of the pelvis that you have outside of this study will be collected.
This is an investigational study.
Up to 300 women will take part in the study. All will be enrolled at MD Anderson.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- University of Texas MD Anderson Cancer Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Patients with histologically confirmed primary or recurrent cervical , endometrial or vaginal cancer. All stages, grades and histologic subtypes will be eligible except neuroendocrine.
- Patients treated with definitive radiation therapy. Patients receiving extended field radiation or brachytherapy in addition to pelvic radiation are eligible. Patients treated with surgery, chemotherapy and/or hormonal therapy in addition to radiation therapy are also eligible.
- Patients must sign an approved informed consent document.
Exclusion Criteria:
- Patients undergoing palliative intent radiation therapy for advanced disease.
- Patients who received prior radiation to the pelvis.
- Patients with an existing pelvic fracture within the proposed radiation field.
- Patients unwilling or unable to provide informed consent for the study.
- Patients with bone metastases.
- Neuroendocrine features present.
- Patients weighing more than 300 lbs are excluded as they cannot be adequately studied in axial skeleton with current bone mineral density software.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
Evaluation Group
Bone Mineral Density Test + MRI or CT + Blood Test
|
During routine visits, a magnetic resonance imaging (MRI) scan or a computed tomography (CT) scan. Blood (about 1 tablespoon) will be drawn to test for bone turnover.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Change in Patient Bone Mineral Density (BMD)
Tidsram: 2 years
|
2 years
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Incidence of pelvic fractures incidence in women treated with definitive pelvic radiation therapy for cervical, endometrial or vaginal cancer
Tidsram: Within 2 years of treatment completion
|
Within 2 years of treatment completion
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Neoplasmer
- Urogenitala neoplasmer
- Neoplasmer efter plats
- Uterina neoplasmer
- Genitala neoplasmer, hona
- Livmoderhalssjukdomar
- Livmodersjukdomar
- Frakturer, ben
- Sår och skador
- Benskador
- Lårbensfrakturer
- Höftskador
- Vaginala sjukdomar
- Uterina cervikala neoplasmer
- Endometriella neoplasmer
- Höftfrakturer
- Vaginala neoplasmer
Andra studie-ID-nummer
- 2008-0023
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Livmoderhalscancer
-
Assiut UniversityHar inte rekryterat ännuCervical Pedicle Skruv
-
NuVasiveAvslutadCervical Degenerative Disc DisorderFörenta staterna
-
Xin Jiang, MDOkänd
-
Duke UniversityUniversity of ArkansasAvslutad
-
National Cancer Institute (NCI)AvslutadLunga | Bröst | Ovarial | Cervical | NjurFörenta staterna
-
Goethe UniversityAvslutadKinematik | Pålitlighet | CervicalTyskland
-
Taipei Veterans General Hospital, TaiwanHar inte rekryterat ännuAnnan Fusion of Spine, Cervical Region
-
NuVasiveAvslutadCervical Degenerative Disc DisorderFörenta staterna
-
NuVasiveAvslutadCervical Degenerative Disc DisorderFörenta staterna
-
Daniel Nalos MDAvslutadCervical Plexus Block JämförelseTjeckien
Kliniska prövningar på CT or MRI + Blood Test
-
Memorial Sloan Kettering Cancer CenterRekryteringFollikulärt lymfomFörenta staterna
-
London Health Sciences CentreAvslutad
-
University Hospital, AngersAvslutadHuntingtons sjukdomFrankrike
-
Assiut UniversityHar inte rekryterat ännuAvbildning av aktiv CSF-rhinorré
-
Assiut UniversityHar inte rekryterat ännu
-
Universitätsmedizin MannheimOkändHjärtsjukdom | Kranskärlssjukdom | HjärtsviktTyskland
-
Roee LandsbergAssuta Medical CenterOkänd
-
University Hospital, Strasbourg, FranceOkändAlzheimers sjukdom | Lewy Bodys demensFrankrike
-
Hospices Civils de LyonRekrytering
-
Al-Azhar UniversityHar inte rekryterat ännu